AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VENLAFAXINE
53 registrations across 8 African markets— 36 active
Markets with VENLAFAXINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| effexor Capsule | 🇰🇪Kenya | Mylan Laboratories Limited, Kenya. | active | Jul 2031 |
| VENLAFAXINE BE-TABS MR 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| VENLAFAXINE BE-TABS MR 75 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| VENLAFAXINE BE-TABS MR 37,5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| VENLAFAXINE UNICORN XR 75 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2025 |
| VENLAFAXINE UNICORN XR 150 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2025 |
| EFFEXOR LP Gélule à libération prolongée / 75 mg | 🇹🇳Tunisia | PFIZER PFE FRANCE | expired | Jan 2023 |
| EFFEXOR LP Gélule à libération prolongée / 37.5 MG | 🇹🇳Tunisia | PFIZER PFE FRANCE | expired | Jan 2023 |
| EFEXOR.XL Gélule à libération prolongée / 150 mg | 🇹🇳Tunisia | Upjohn UK Limited | expired | Jan 2022 |
| VENLAXAFIN SANDOZ RETARD Gélule à libération prolongée / 75 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | Jan 2020 |
| VENLAXAFIN SANDOZ RETARD Gélule à libération prolongée / 150 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | May 2019 |
| EFFEXINE L.P. Gélule à libération prolongée / 37.5 mg | 🇹🇳Tunisia | ADWYA | expired | Sept 2014 |
| EFFEXINE L.P. Gélule à libération prolongée / 75 mg | 🇹🇳Tunisia | ADWYA | expired | Sept 2014 |
| ZENEXOR LP Gélule à libération prolongée / 75 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Nov 2010 |
| ZENEXOR LP Gélule à libération prolongée / 37.5 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Nov 2010 |
| TEDEMA LP Gélule à libération prolongée / 37.5 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Apr 2009 |
| TEDEMA Comprimé pelliculé / 50 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jan 2009 |
| TEDEMA Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jan 2009 |
| VENLOR XR 37,5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| VENEXOR XR 37,5 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| VENEXOR XR 150 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| EFEGEN XR 75 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Jan 1900 |
| EFEGEN XR 150 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Jan 1900 |
| VENEXOR XR 75 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| VENLOR XR 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ILLOVEX XR 300 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Jan 1900 |
| VENLOR XR 75 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ACCORD VENLAFAXINE 150 mg XR | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| ODIVEN 37,5 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 1900 |
| ODIVEN 50 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 1900 |
| ODIVEN 75 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 1900 |
| ACCORD VENLAFAXINE 75 mg XR | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| MYLAN VENLAFAXINE 75 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| MYLAN VENLAFAXINE 150 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| VENLAFAXINE 150 mg XL AUSTELL | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| EFEXOR XR 75 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| VENLAFAXINE 75 mg XL AUSTELL | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| VENLAFAXINE XR 75 ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| EFEXOR XR 150 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| TEDEMA LP gelule a liberation prolongee / 37,5 mg | 🇸🇳Senegal | MEDIS | active | — |
| EFFEXOR COMPRIME | 🇲🇦Morocco | — | active | — |
| EFFEXOR LP 37,5MG GELULE A LIBERATION PROLONGEE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LABORATOIRE VIATRIS | active | — |
| EFFEXOR COMPRIME | 🇲🇦Morocco | — | active | — |
| EFTRO 75 Capsules | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| EFFEXOR® L.P. 37,5MG GELU LP BTE (3 X 10) PFIZER GLOBAL gélule à libération prolongée, | 🇲🇬Madagascar | VIATRIS UP | active | — |
| EFFEXOR LP gélule / 75 mg | 🇸🇳Senegal | PFIZER HOLDING FRANCE | active | — |
| VELAXOR LP GELULE LP | 🇲🇦Morocco | — | active | — |
| EFFEXOR LP 75 MG GELULE LP | 🇲🇦Morocco | — | active | — |
| EFTRO 150 Capsules | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| EFFEXOR LP 75 MG GELULE LP | 🇲🇦Morocco | — | active | — |
Showing 50 of 53 registrations. Sign up free to search and export all.
VENLAFAXINE in Africa — Regulatory Overview
VENLAFAXINE is registered across 8 African markets with 53 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Senegal and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 53 registrations, 36 (68%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.